Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barni

Showing results (351-360 of 369) with videos related to

Pageof 37
Sort By:
British Journal of Cancer|March 1, 2002
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimenS Cascinu, A M Baldelli, V Catalano, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
How to study boron biodistribution in liver metastases from colorectal cancerL Roveda, U Prati, J Bakeine, et al.
Urologia Internationalis|April 27, 2000
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patientsV Bordin, L Giani, S Meregalli, et al.
Oncology|October 2, 2004
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-upS Barni, E Piazza, L Frontini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract CancerR Labianca, S Cascinu, L Frontini, et al.
Lancet (London, England)|April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapyR Passalacqua, F Campione, C Caminiti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer ProjectL Crinò, G V Scagliotti, S Ricci, et al.
Allergologia Et Immunopathologia|October 15, 2018
Cooking influence in tolerance acquisition in egg-induced acute food protein enterocolitis syndromeS Miceli Sopo, A Romano, G Bersani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centersA Sobrero, A Zaniboni, G L Frassineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)S Cascinu, F Graziano, F Ferraù, et al.
Pageof 37

Showing results (351-360 of 369) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|March 1, 2002
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimenS Cascinu, A M Baldelli, V Catalano, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
How to study boron biodistribution in liver metastases from colorectal cancerL Roveda, U Prati, J Bakeine, et al.
Urologia Internationalis|April 27, 2000
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patientsV Bordin, L Giani, S Meregalli, et al.
Oncology|October 2, 2004
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-upS Barni, E Piazza, L Frontini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract CancerR Labianca, S Cascinu, L Frontini, et al.
Lancet (London, England)|April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapyR Passalacqua, F Campione, C Caminiti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer ProjectL Crinò, G V Scagliotti, S Ricci, et al.
Allergologia Et Immunopathologia|October 15, 2018
Cooking influence in tolerance acquisition in egg-induced acute food protein enterocolitis syndromeS Miceli Sopo, A Romano, G Bersani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centersA Sobrero, A Zaniboni, G L Frassineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)S Cascinu, F Graziano, F Ferraù, et al.
Pageof 37